Filter
642
Filtered Results: 642
Text search:
Regional
Office
for
the
Eastern
Mediterreanan
Featured
Recommendations
91
New Publications
133
Language
Document type
No document type
228
Studies & Reports
171
Guidelines
111
Manuals
51
Strategic & Response Plan
33
Training Material
11
Situation Updates
11
Fact sheets
11
Infographics
6
Resource Platforms
5
Brochures
1
App
1
Online Courses
1
Videos
1
Countries / Regions
Global
59
Syria
22
Africa
17
Middle East and North Africa
15
Western and Central Europe
13
Somalia
9
Yemen
8
Pakistan
6
South–East Asia Region
6
Eastern Europe
6
Nigeria
5
Sudan
5
Latin America and the Carribbean
5
Sierra Leone
4
Liberia
4
Ethiopia
4
Iraq
4
Jordan
4
Afghanistan
4
Lebanon
4
Myanmar / Burma
4
Saudi Arabia
3
Ghana
3
Turkey
3
Kenya
3
Rwanda
3
Iran
3
Senegal
2
Philippines
2
India
2
Nepal
2
Thailand
2
China
2
South Africa
2
North Macedonia
2
Ukraine
2
Libya
2
East and Southern Africa
2
West and Central Africa
2
Western Pacific Region
2
Asia
2
Venezuela
2
Congo, Democratic Republic of
1
Morocco
1
USA
1
Cameroon
1
Uganda
1
Egypt
1
Tanzania
1
Cambodia
1
Bangladesh
1
Benin
1
Croatia
1
Ecuador
1
Greece
1
Chile
1
Eastern Europe and Central Asia
1
Palestine
1
Albania
1
Djibouti
1
Russia
1
Qatar
1
Georgia
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
87
Countries
83
Public Health
68
Women & Child Health
55
Key Resources
34
Pharmacy & Technologies
14
Capacity Building
13
Toolboxes
Mental Health
81
COVID-19
72
Planetary Health
43
Rapid Response
38
TB
35
HIV
32
Conflict
29
Refugee
29
NTDs
28
Global Health Education
26
Caregiver
26
AMR
25
Disability
20
NCDs
20
Pharmacy
15
Ebola
9
Polio
9
Zika
6
Cholera
5
Natural Hazards
5
Specific Hazards
4
Health Financing Toolbox
4
Typhoon
1
The country profiles incorporate facts indicating the national status of medical devices in areas such as: medical device policies, regulations, incorporation, lists, inventories, nomenclature, he...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements ... 2023 to carry out health interventions in emergency and humanitarian responses. The number of people in need of humanitarian relief has increased by almost a quarter compared to 2022, to a record 339 million. WHO is responding to an unprecedented number of intersecting health emergencies: climate change-related disasters such as flooding in Pakistan and food insecurity across the Sahel in the greater Horn of Africa; the war in Ukraine; and the health impact of conflict in Yemen, Afghanistan, Syria and north eastern Ethiopia – all of these emergencies overlapping with the health system disruptions caused by the COVID-19 pandemic and outbreaks of measles, cholera, and other killers. Contributions to the appeal can be fully flexible, flexible across a region, or flexible within a country appeal.
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment ... children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delamanid in young children with multidrug- and rifampicin-resistant TB and decentralized and family-centred, integrated models of care for TB case detection and prevention in children and adolescents.
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of ... COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly replacing Delta worldwide – was considered Omicron has a substantial growth advantage, higher secondary attack rates and a higher observed reproduction number than Delta.
There is now significant evidence that immune evasion contributes to the rapid spread of Omicron. Other factors may be a shorter
serial interval (by about 0.8 to 1.2 days compared to Delta) and potential increased intrinsic transmission fitness . There is
growing evidence that with Omicron, there is lower vaccine effectiveness (VE) against infection and symptomatic disease soon after vaccination compared to Delta. There is also evidence of accelerated waning of VE over time of the primary series against infection and symptomatic disease for the studied vaccines. Further studies are required to better understand the drivers of transmission and declining incidence in various settings. These factors include the intrinsic transmission fitness properties of the virus, degree of immune evasion, vaccination coverage and level of vaccine-derived and post-infection immunity, levels of social mixing and degree of application of public health and social measures (PHSM).
People with underlying noncommunicable diseases (NCDs) such as hypertension, diabetes, cardiovascular disease, chronic respiratory disease and cancer have a high risk for developing severe and even fatal COVID-19. It is important ... them to strictly follow basic protective measures and make sure their chronic diseases are well managed. However, pandemics cripple health systems and compromise provision routine medical care. This technical note gives general guidance to people living with NCDs, their caregivers and family members, the public, health programme managers and health-care workers on how to reduce risks of a COVID-19 infection and maintain care for people living with NCDs during the outbreak.
Every day in 2020, approximately 800 women died from preventable causes related to pregnancy and childbirth - meaning that a woman dies around every two minutes.
Sustainable Development Goal (SDG) target 3.1 is to reduce maternal mortality to less than 70 maternal deaths per 100 000 live births by ...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the d...
Only 8,730 asylum applications were registered in the EU+ in April, the lowest since at least 2008, and a massive 87% decrease from pre-COVID-19 levels in January and February.
... European Asylum Support Office (EASO) has released a special report which shows that the COVID-19 related travel restrictions and national health measures which were imposed during the past few months led to a dramatic cut in asylum applications in Europe.
The Global Vaccine Action Plan (GVAP) 2011-2020, endorsed by Member States during the May 2012 World Health Assembly, has set ambitious targets to improve access to immunization and tackle vaccine-p...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited a...
This report reviews the current situation in relation to national capacity to address NCDs and the progress made at country level over the past dec...
This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementati...
The main objective of the malaria prevention and control programme in Somalia is to prevent mortality and reduce morbidity due to malaria. The grou...
The objectives of NAP are aligned with the global action plan based on national needs and priorities. The emphasis is on One Health approach with a...
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health profes...
Practical actions in cities to strengthen preparedness for the COVID-19 pandemic and beyond
recommended
This document accompanies the interim guidance on “Strengthening Preparedness for COVID-19 in cities and urban settings”. It provides local authorities, leaders and policy-makers in cities with ...
